Skip to main content
Menu
US

IVISense MMP 750 FAST Fluorescent Probe (MMPSense)

Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.

Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.

Feature Specification
Unit Size 1 vial (10 doses)
Specificity Matrix Metalloprotease

Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.

Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.

Product Variants
Wave Length: 645 nm
Part #:
NEV10100
List Price
USD 706.60
Your online price:
Wave Length: 680 nm
Part #:
NEV10126
List Price
USD 702.04
Your online price:
Wave Length: 750 nm
Part #:
NEV10168
List Price
USD 702.04
Your online price:
For research use only. Not for use in diagnostic procedures.
Total list price:
USD 702.04
Log in to view your online price

Overview

IVISense MMP 750 FAST is excited by 749 nm excitation light, and emits at 775 nm. MMP 750 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture termed F.A.S.T. (Fluorescent Activatable Sensor Technology), that allows for an earlier optimal imaging window of 12-24 hours after injection, facilitating detection of MMP activity changes in acute models of inflammation or stroke. In addition, the 750 nm wavelength is optimal for minimizing the impact of autofluorescence and chow-related fluorescence that can interfere with image quality. Including IVISense MMP 750 FAST in careful experimental design allows for multiplexing with other channels and/or imaging times, and so can be paired with other probes to achieve maximum efficiency and flexibility in imaging.

Specifications

Brand
IVISense
Fluorescent Agent Type
Enzyme activated
Imaging Modality
Fluorescence
Shipping Conditions
Shipped in Blue Ice
Specificity
Matrix Metalloprotease
Storage Conditions
-30 to -16 °C
Therapeutic Area
Arthritis
Atherosclerosis
Cardiovascular
Inflammation
Oncology
Pulmonary
Vascular
Unit Size
1 vial (10 doses)
Wave Length
750 nm

Resources

Are you looking for resources, click on the resource type to explore further.

7-10 of 10 Resources
Application Note Icon
Application Note
Quantitative analysis of 3D microtissue growth and biomarker intensity
Protocol/SOP
Protocol/SOP
SOP: IVISense MMP 750 FAST (NEV10168) for in vivo imaging
Publication Icon
Literature - Publication Review
The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells
Whitepaper Icon
Whitepaper
Understanding the ‘how’ and ‘why’ of spectral unmixing

In vivo fluorescence imaging displays a very broad utility and has become a well-established modality for functional imaging in...

Loading...

Scroll Icon